Engaging patients, advocates, and researchers to improve the lives of young people with rare cancers
MyPART is a group of scientists, patients, family members, advocates, and healthcare providers working on rare tumors.
You can help speed up the development of new treatments by giving researchers the tools they need.
Non-profit organizations are important members of the MyPART network.
MyPART studies rare solid tumors affecting children and young adults.
Dr. Brigitte Widemann, leader of MyPART, describes her recent success developing treatment for a rare tumor, plexiform neurofibroma, and how natural history studies at NIH lay the foundation for finding new treatments for rare tumors.